Hancock Whitney’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
Hancock Whitney's ANGO Position: Q2 2020 in Review
Hancock Whitney sold out of AngioDynamics (ANGO) in Q2 2020, closing a stake of 132,653 shares — an estimated $1.38M sold.
Hancock Whitney first reported a position in ANGO in Q3 2018 and held it in 7 quarters. The position peaked at $3.29M in Q1 2019. 146 funds tracked by Wall St. Rank hold ANGO as of Q2 2020.
- Hancock Whitney reported no remaining AngioDynamics position as of Q2 2020 after selling out during the quarter.
- Hancock Whitney sold 132,653 AngioDynamics shares in Q2 2020, an estimated $1.38M.
- Hancock Whitney first reported a position in AngioDynamics in Q3 2018 and held it in 7 quarters.
- Hancock Whitney's AngioDynamics position peaked at $3.29M in Q1 2019.
- 146 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2020.
Based on Hancock Whitney's 13F filing for Q2 2020, filed 30 Jul 2020.